athagoras has acquired confinis ag, enhancing its regulatory and compliance capabilities in the Life Sciences sector across Europe and North America.

Information on the Target

Founded in 2005 and headquartered in Düdingen, Switzerland, confinis ag is a consulting firm that specializes in regulatory affairs, quality assurance, and compliance solutions tailored for the MedTech and pharmaceutical sectors across Europe and North America. The company has established a strong reputation characterized by its scientific depth and operational excellence, fostering long-term, trust-based relationships with over 100 active clients.

confinis offers a comprehensive range of services, including regulatory submissions, quality management system (QMS) implementation, clinical documentation, and post-market support. With its innovative approach and dedication to excellence, confinis is poised to become a strategic addition to the athagoras platform.

Industry Overview

The regulatory consulting industry in Switzerland is marked by a robust demand for services that ensure compliance with stringent international standards in the life sciences sector. Switzerland is home to numerous pharmaceutical and medic

View Source

Similar Deals

Tecan Group Wako Automation

2025

Merger Biopharmaceuticals Switzerland
NeuroX Group SA Relief Therapeutics Holding SA

2025

Merger Proprietary & Advanced Pharmaceuticals Switzerland
GE HealthCare Intelerad

2026

Merger Medical Imaging Systems United States of America
Novartis AG Avidity Biosciences, Inc.

2026

Merger Proprietary & Advanced Pharmaceuticals United States of America
Laborie Medical Technologies Corp. JADA System

2026

Merger Medical Devices & Implants United States of America
DeepTech & Climate Fonds NUCLIDIUM AG

2025

Series B Bio Therapeutic Drugs Switzerland

athagoras

invested in

confinis ag

in 2025

in a Merger deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert